LEK-8841

LEK-8841, also known as N-methyl-N-(2-propynyl)-2-bromolysergamide or as 2-bromo-LEK-8842, is a monoamine receptor modulator of the lysergamide family related to 2-bromo-LSD.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LEK-8841, also known as N-methyl-N-(2-propynyl)-2-bromolysergamide or as 2-bromo-LEK-8842, is a monoamine receptor modulator of the lysergamide family related to 2-bromo-LSD. It is the 2-bromo derivative of LEK-8842.

The drug shows affinity for serotonin 5-HT 2 and α 1 -adrenergic receptors (K i = 16.3 nM at 5-HT 2 ) and acts as a silent antagonist of these receptors (A 2 = 11.7 nM and 355 nM, respectively), with activity described as qualitatively similar to that of ketanserin but with greater selectivity for serotonin 5-HT 2 receptors over α 1 -adrenergic receptors. However, LEK-8841 was also subsequently found to interact with the dopamine D 1 and D 2 receptors (K i = 360 nM and 11.3 nM, respectively).

The drug inhibits apomorphine-induced hyperlocomotion and climbing behavior, induces catalepsy, inhibits the 5-hydroxytryptophan (5-HTP)-induced head twitch response, and produces hypotension in rodents. LEK-8841 was first described in the scientific literature by 1992. It was developed by the Slovenian pharmaceutical company LEK Pharmaceuticals.

The drug has been suggested as a potential clinically effective antipsychotic for medical use. Based on ratio of dopamine D 2 receptor antagonism to serotonin 5-HT 2 receptor antagonism, it is said to appear more like a typical than atypical antipsychotic.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1364275521 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.